etidronate has been researched along with hydroxyproline in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 65 (79.27) | 18.7374 |
1990's | 14 (17.07) | 18.2507 |
2000's | 3 (3.66) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Broom, MF; Goulding, A | 1 |
Bijvoet, OL; Hosking, DJ; van Aken, J; Will, EJ | 1 |
Singer, FR | 1 |
Lemaire, V; Ryckewaert, A; Tubiana, M | 1 |
Ryan, WG | 1 |
Cullen, JC; Fraser, TR; Henley, JW; Ibbertson, HK; Scott, DJ; Stephens, ES; Tait, B; Wattie, DJ | 1 |
Chan, MM; Riggins, RS; Rucker, RB | 1 |
Black, HE; Capen, CC; Geho, WB; Potts, JT; Re, R; Yarrington, JT | 2 |
Dietz, GW; Geho, WB; Haussler, M; Kaplan, RA; Pak, CY; Poindexter, C | 1 |
Culebras, A; Feldman, RG; Schmidek, HH | 1 |
Bohne, W; Canfield, R; Feldman, F; Kammerman, S; Kunigonis, M; McWhorter, J; Resnick, L; Rosner, W; Ryan, K; Skinner, J | 1 |
Byrne, M; Kantrowitz, FG; Krane, SM; Pinnell, SR; Singer, FR | 1 |
Goulding, A; McChesney, R | 1 |
Krane, SM | 1 |
Johnston, C; Khairi, A; Rashid, M | 1 |
Altman, RD; DeRosa, GP; Johnston, CC; Khairi, MR; Schenk, RK; Zimmermann, J | 1 |
Bijvoet, OL; de Vries, HR; Froeling, PG | 1 |
Caniggia, A; Gennari, C; Guideri, R; Nardi, P; Vattimo, A | 1 |
Bernard, J; Chapuy, MC; Courpron, P; Edouard, C; Meunier, P; Vignon, E | 1 |
Bijvoet, OL; Hosking, DJ | 1 |
Francis, MJ; Smith, R; Walton, RJ; Whiteley, J | 1 |
Burkhardt, P; Courvoisier, B; Epiney, J; Jung, A; Mermillod, B; Schenk, R | 1 |
Beard, DJ; Beneton, M; Harris, S; Kanis, JA; Preston, CJ; Russell, RG | 1 |
Bevan, J; Fogelman, I; Hart, DM; Leggate, I; Scott, E; Smith, ML | 1 |
Kuntz, D; Miravet, L | 1 |
Meunier, PJ; Ravault, A | 1 |
Fournié, A; Fournié, B; Lassoued, S | 1 |
Beneton, MN; Galloway, J; Harris, S; Kanis, JA; McCloskey, EV; Yates, AJ | 1 |
Bijvoet, OL; Blanksma, HJ; Dahlinghaus-Nienhuys, PJ; Harinck, HI | 1 |
Avioli, LV | 1 |
Clemens, TL; Gordon, AC; Gundberg, CM; Jacobs, TP; Reich, L; Shane, E; Silverberg, SJ | 1 |
Beneton, MN; Gray, RE; Kanis, JA; Preston, CJ; Russell, RG; Smith, R; Yates, AJ | 1 |
Beneton, MN; Gray, RE; Hamdy, NA; Kanis, JA; McCloskey, EV; Murray, SA; Urwin, GH | 1 |
Alexandre, C; Chapuy, MC; Charhon, S; Delmas, P; Mathieu, L; Meunier, PJ; Salson, C | 1 |
Holz-Gottswinter, G; Raue, F; Wilder-Smith, CH; Ziegler, R | 1 |
Hosking, DJ; O'Donoghue, DJ | 1 |
Hatayama, T; Hida, S; Kawamura, J; Komatsu, Y; Mori, O; Saito, K; Suzuki, N; Tochigi, H; Yanagawa, M; Yoshida, O | 1 |
Boyce, BF; Boyle, IT; Cowan, RA; Fogelman, I; Jenkins, A; Ralston, SH; Smith, ML | 1 |
Anderson, DC; Dewis, P; Prasad, BK; Willets, S | 1 |
Frühwald, F; Kolbe, H; Kovarik, J; Niebauer, B; Woloszczuk, W | 1 |
Crielaard, JM; Diverse, P; Franchimont, P; Gritten, C; Halleux, R; Hauwaert, PC; Reginster, JY | 1 |
Altman, RD | 1 |
Castro Beiras, JM; Elena Ibáñez, A; García Vadillo, A; Morales Piga, A; Rodríguez García, A; Rodríguez Torrás, M | 1 |
Preston, C; Russell, RG; Smith, R; Walton, RJ; Woods, CG | 1 |
Altman, RD; Johnston, CC; Khairi, MR; Sankey, RR; Serafini, AN; Wellman, H | 1 |
Bishop, M; Bishop, MC; Russell, RG; Smith, R; Woods, CG | 1 |
Altman, RD; Johnston, CC; Khairi, MR; Sankey, RR; Serafini, AN; Wellman, HN | 1 |
Vaisrub, S | 1 |
Nuti, R; Righi, G; Turchetti, V; Vattimo, A | 2 |
Baldauf, G; Ziegler, R | 1 |
Alexandre, CM; Chapuy, MC; Edouard, C; Johnston, CC; Meunier, PJ; Vignon, E | 1 |
Mautalen, CA | 1 |
Boyce, BF; Boyle, IT; Fogelman, I; Ralston, S; Smith, ML | 1 |
Dodd, G; Fraser, TR; Holdaway, IM; Ibbertson, HK; King, A; Rutland, M; Wattie, DJ | 1 |
Bijvoet, OL; de Vries, E; Frijlink, WB; Jie, K; Meijer, CJ; Mulder, H; Reitsma, PH; te Velde, J; van der Linden, H; van der Wey, JP; van Paassen, HC | 1 |
Arlot, ME; Meunier, PJ | 1 |
Johnston, CC; Khairi, MR; Meunier, PJ | 1 |
Baquiran, DC; Canfield, RE; Jacobs, TP; Siris, ES | 1 |
Alexandre, C; Arlot, M; Bressot, C; Chapuy, MC; Edouard, C; Johnston, CC; Mathieu, L; Meunier, PJ; Vignon, E | 1 |
Norman, DA; Pak, CY; Zerwekh, JE | 1 |
Courvoisier, B; Davoine, GA; Jung, A | 1 |
Bischoff-Delaloye, A; Burckhardt, P; Jaeger, P | 1 |
Casco, C; Fogel, M; Ghiringhelli, G; Mautelén, C; Nusimovich, B; Varela de Rodríguez, J | 1 |
Assiri, AM; Blumsohn, A; Eastell, R; Naylor, KE | 1 |
Devogelaer, JP; Dougados, M; Farrerons, J; Gennari, C; Kruse, HP; Mulder, H; Picot, C; Reginster, JY; Roux, C; Titeux, L | 1 |
Dempster, D; Lindsay, R; Parisien, M; Shane, E; Singer, F; Siris, E | 1 |
Gunasekera, RD; Wimalawansa, SJ | 1 |
Ballah, A; Hosking, DJ; Mundy, GR; Reasner, CA; Stone, MD | 1 |
Meunier, PJ; Vignot, E | 1 |
Hasegawa, Y; Ito, T; Iwase, T; Iwata, H; Makihara, N; Takahashi, H | 1 |
Drent, G; Groen, EW; Haagsma, EB; Meerman, L; Oostdijk, A; Piers, DA; Riemens, SC; Slooff, MJ; Thijn, CJ; van Doormaal, JJ | 1 |
de la Piedra, C; Diaz Diego, EM; Diaz Martin, MA; Disla, T; Guerrero, R; Rapado, A | 1 |
Bayraktar, M; Gedik, O; Gürlek, A | 1 |
Arnala, I; Heikkinen, JE; Laitinen, K; Selander, KS; Väänänen, HK | 1 |
Bekker, PJ; Clemens, TL; Eusebio, RA; Singer, FR | 1 |
Itoh, T; Kawasaki, K; Koga, K; Kohno, S; Nonaka, K; Yamada, K | 1 |
Kocijancic, A; Komel, R; Marc, J; Prezelj, J | 1 |
Eisman, J; Glanville, A; Henderson, K; Keogh, A; MacDonald, P; Sambrook, P; Spratt, P | 1 |
Ikemoto, M; Kano, M; Katunuma, N; Kishi, K; Kitano, T; Nikawa, T; Shizuka, F; Towatari, T; Watanabe, C; Yoshimoto, M | 1 |
Burnashova, ZA; Valeeva, IKh; Ziganshin, AU; Ziganshina, LE | 1 |
3 review(s) available for etidronate and hydroxyproline
Article | Year |
---|---|
Paget's disease of bone.
Topics: Bone and Bones; Calcitonin; Calcium; Collagen; Etidronic Acid; Humans; Hydroxylysine; Hydroxyproline; Osteitis Deformans; Procollagen | 1977 |
Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
Topics: Alkaline Phosphatase; Bone and Bones; Calcitonin; Calcium; Deafness; Etidronic Acid; Fractures, Bone; Gastrointestinal Diseases; Hemodynamics; Humans; Hydroxyproline; Osteitis Deformans; Pain; Parathyroid Hormone; Phosphorus; Radionuclide Imaging | 1977 |
Paget's disease: state of the art.
Topics: Alkaline Phosphatase; Calcitonin; Etidronic Acid; Humans; Hydroxyproline; Osteitis Deformans; Plicamycin | 1987 |
19 trial(s) available for etidronate and hydroxyproline
Article | Year |
---|---|
Metabolic effects of diphosphonate in primary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Calcium; Clinical Trials as Topic; Cyclic AMP; Dihydroxycholecalciferols; Etidronic Acid; Female; Humans; Hydroxyproline; Hyperparathyroidism; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphates; Time Factors | 1977 |
Diphosphonate therapy of paget's disease of bone.
Topics: Alkaline Phosphatase; Clinical Trials as Topic; Dose-Response Relationship, Drug; Etidronic Acid; Female; Fractures, Bone; Humans; Hydroxyproline; Male; Osteitis Deformans | 1977 |
Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Bone Matrix; Clinical Trials as Topic; Etidronic Acid; Female; Fractures, Bone; Gastrointestinal Diseases; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Osteoblasts; Osteoclasts; Pain; Remission, Spontaneous; Risk; Time Factors | 1977 |
Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
Topics: Alkaline Phosphatase; Calcitonin; Clinical Trials as Topic; Drug Therapy, Combination; Etidronic Acid; Humans; Hydroxyproline; Organophosphorus Compounds; Osteitis Deformans | 1976 |
Effect of etidronate disodium on bone turnover following surgical menopause.
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Calcium-Binding Proteins; Etidronic Acid; Female; Humans; Hydroxyproline; Hysterectomy; Menopause; Middle Aged; Organometallic Compounds; Organotechnetium Compounds; Osteocalcin; Osteoporosis; Ovariectomy; Technetium | 1989 |
Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
Topics: Administration, Oral; Alkaline Phosphatase; Biopsy; Bone and Bones; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Osteitis Deformans; Pamidronate; Remission Induction; Time Factors | 1987 |
The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.
Topics: Alkaline Phosphatase; Calcitriol; Creatinine; Double-Blind Method; Etidronic Acid; Humans; Hydroxyproline; Minerals; Osteitis Deformans; Random Allocation | 1987 |
Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.
Topics: Aged; Alkaline Phosphatase; Clinical Trials as Topic; Creatinine; Diphosphonates; Etidronic Acid; Humans; Hydroxyproline; Middle Aged; Osteitis Deformans; Pamidronate | 1985 |
Long-term follow-up of therapy with intermittent etidronate disodium in Paget's disease of bone.
Topics: Aged; Alkaline Phosphatase; Clinical Trials as Topic; Drug Resistance; Etidronic Acid; Female; Follow-Up Studies; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Time Factors | 1985 |
Diphosphonates in Paget's disease.
Topics: Administration, Oral; Alkaline Phosphatase; Biopsy; Bone and Bones; Bone Resorption; Calcium; Clinical Trials as Topic; Dose-Response Relationship, Drug; Etidronic Acid; Humans; Hydroxyproline; Organophosphorus Compounds; Osteitis Deformans; Phosphates | 1974 |
Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Etidronic Acid; Female; Fluorides; Humans; Hydroxyproline; Isotopes; Male; Middle Aged; Organophosphorus Compounds; Osteitis Deformans; Pain; Placebos; Radiography; Strontium Isotopes; Time Factors | 1973 |
Treatment of Paget disease of bone (osteitis deformans). Results of a one-year study with sodium etidronate.
Topics: Age Factors; Aged; Alkaline Phosphatase; Clinical Trials as Topic; Drug Evaluation; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Organophosphorus Compounds; Osteitis Deformans; Phosphorus; Placebos; Radiography; Radionuclide Imaging; Remission, Spontaneous; Time Factors | 1974 |
[Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
Topics: Adult; Aged; Alkaline Phosphatase; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Hormones; Humans; Hydroxyproline; Middle Aged; Osteitis Deformans; Radionuclide Imaging | 1981 |
Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Prospective Studies; Time Factors | 1995 |
Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
Topics: Alkaline Phosphatase; Calcitonin; Creatinine; Diphosphonates; Drug Administration Schedule; Drug Resistance; Etidronic Acid; Humans; Hydroxyproline; Infusions, Intravenous; Osteitis Deformans; Pain; Pamidronate | 1993 |
Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study.
Topics: Absorptiometry, Photon; Administration, Intranasal; Aged; Analysis of Variance; Biomarkers; Bone Density; Calcitonin; Calcitriol; Drug Synergism; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Hydroxyproline; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Treatment Outcome; Turkey | 1997 |
Short-term intravenous bisphosphonates in prevention of postmenopausal bone loss.
Topics: Absorptiometry, Photon; Bone Density; Calcitriol; Calcium; Clodronic Acid; Collagen; Collagen Type I; Creatinine; Dose-Response Relationship, Drug; Double-Blind Method; Etidronic Acid; Female; Femur Neck; Follow-Up Studies; Humans; Hydroxyproline; Injections, Intravenous; Longitudinal Studies; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Peptide Fragments; Peptides; Procollagen; Prospective Studies | 1997 |
VDR genotype and response to etidronate therapy in late postmenopausal women.
Topics: Aged; Biomarkers; Bone Density; Calcium; Etidronic Acid; Female; Genotype; Humans; Hydroxyproline; Lumbar Vertebrae; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Polymorphism, Restriction Fragment Length; Receptors, Calcitriol | 1999 |
Protective effect of short-tem calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation.
Topics: Adrenal Cortex Hormones; Adult; Calcitriol; Calcium; Cyclosporine; Etidronic Acid; Female; Fractures, Bone; Heart Transplantation; Humans; Hydroxyproline; Lung Transplantation; Male; Middle Aged; Osteocalcin; Osteoporosis | 2001 |
60 other study(ies) available for etidronate and hydroxyproline
Article | Year |
---|---|
Effects of diphosphonate and colchicine administration upon acid-base changes induced in rats by bilateral nephrectomy.
Topics: Acid-Base Equilibrium; Acids; Animals; Colchicine; Etidronic Acid; Hydrogen-Ion Concentration; Hydroxyproline; Hypercalcemia; Male; Nephrectomy; Potassium; Rats; Urea; Uremia | 1979 |
Paget's bone disease treated with diphosphonate and calcitonin.
Topics: Aged; Alkaline Phosphatase; Bone and Bones; Calcitonin; Drug Evaluation; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Organophosphorus Compounds; Osteitis Deformans | 1976 |
Treatment of Paget's disease of bone.
Topics: Alkaline Phosphatase; Calcitonin; Etidronic Acid; Humans; Hydroxyproline; Injections, Intravenous; Injections, Subcutaneous; Organophosphonates; Osteitis Deformans; Plicamycin; Radiography | 1975 |
[Non-hormonal drug treatment in Paget's disease].
Topics: Alkaline Phosphatase; Etidronic Acid; Humans; Hydroxyproline; Organophosphorus Compounds; Osteitis Deformans; Osteomalacia; Plicamycin | 1975 |
Paget's disease of bone.
Topics: Adult; Bone and Bones; Calcitonin; Calcium; Collagen; Dactinomycin; Etidronic Acid; Fluorides; Glucagon; Humans; Hydroxyproline; Osteitis Deformans; Parathyroid Hormone; Phosphates; Plicamycin; Regional Blood Flow | 1977 |
Paget's disease of bone: assessment and management.
Topics: Aged; Alkaline Phosphatase; Analgesics; Calcitonin; Etidronic Acid; Humans; Hydroxyproline; Middle Aged; Osteitis Deformans; Pain; Plicamycin | 1979 |
Effects of fluoride and ethane-1-hydroxy-1,1-diphosphonate on bone metabolism in the growing chick.
Topics: Alkaline Phosphatase; Animals; Apatites; Body Weight; Bone and Bones; Calcium; Chick Embryo; Cyclic AMP; Etidronic Acid; Femur; Fluorides; Hydroxyproline; Magnesium; Male; Minerals; Organophosphorus Compounds; Phosphorus; Pyrophosphatases | 1976 |
Experimental parturient hypocalcemia in cows following prepartal chemical inhibition of bone resportion.
Topics: Animals; Antigens; Bone Resorption; Calcium; Calcium, Dietary; Cattle; Cattle Diseases; Cyclic AMP; Disease Models, Animal; Etidronic Acid; Female; Homeostasis; Hydroxyproline; Hypocalcemia; Organophosphorus Compounds; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Pregnancy; Puerperal Disorders; Thyroid Gland | 1976 |
Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on the ultrastructure of parathyroid glands and plasma immunoreactive parathyroid hormone in pregnant cows fed a low calcium diet.
Topics: Animals; Antigens; Calcium; Calcium, Dietary; Cyclic AMP; Duodenum; Etidronic Acid; Female; Homeostasis; Humans; Hydroxyproline; Intestinal Mucosa; Lactation; Magnesium; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Pregnancy; Pregnancy, Animal; Thyroid Gland; Time Factors | 1977 |
Paget's disease and the nervous system.
Topics: Adult; Alkaline Phosphatase; Calcitonin; Etidronic Acid; Humans; Hydrocephalus; Hydroxyproline; Middle Aged; Nervous System Diseases; Osteitis Deformans; Peripheral Nervous System Diseases; Plicamycin; Sarcoma; Skull Neoplasms; Spinal Cord Compression | 1979 |
Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
Topics: Adolescent; Adult; Amino Acids; Bone and Bones; Burns; Calcitonin; Child; Collagen; Etidronic Acid; Fascia; Female; Glycosides; Humans; Hydroxylysine; Hydroxyproline; Male; Middle Aged; Osteitis Deformans | 1977 |
Comparison of effects of parathyroidectomy and ethane-1-hydroxy-1,1-diphosphonate (EHDP) administration upon bone synthesis of hydroxyproline and urinary excretion of hydroxyproline in rats.
Topics: Animals; Collagen; Etidronic Acid; Femur; Hydroxyproline; Male; Parathyroid Glands; Parathyroid Hormone; Proline; Rats; Tritium | 1977 |
Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate.
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Organophosphorus Compounds; Osteitis Deformans | 1975 |
[Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Etidronic Acid; Humans; Hydroxyproline; Organophosphorus Compounds; Osteitis Deformans | 1976 |
[Clinical, biological and histological effects of ethane-1-hydroxy 1, 1-diphosphonate (EDHP) in Paget's disease].
Topics: Alkaline Phosphatase; Bone and Bones; Etidronic Acid; Humans; Hydroxyproline; Organophosphorus Compounds; Osteitis Deformans; Osteoclasts | 1975 |
Serum proline imino-peptidase activity in normal adult subjects and in patients with Paget's disease of bone.
Topics: Adult; Aged; Alkaline Phosphatase; Aminopeptidases; Dietary Proteins; Etidronic Acid; Female; Gelatin; Humans; Hydroxyproline; Liver Diseases; Male; Middle Aged; Osteitis Deformans; Proline | 1976 |
[Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
Topics: Aged; Alkaline Phosphatase; Biopsy; Bone and Bones; Etidronic Acid; Female; Humans; Hydroxyproline; Ilium; Male; Middle Aged; Osteitis Deformans | 1976 |
Comparative effects of an antiviral drug, inosiplex, and diphosphonates in Paget's disease of bone.
Topics: Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hydroxyproline; Inclusion Bodies, Viral; Inosine; Inosine Pranobex; Osteitis Deformans | 1985 |
[Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcitonin; Diphosphonates; Drug Administration Schedule; Drug Resistance; Etidronic Acid; Female; Follow-Up Studies; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate | 1989 |
[Long-term follow-up of 88 patients with Paget's disease treated by discontinuous courses of low-dose disodium etidronate].
Topics: Adult; Aged; Alkaline Phosphatase; Drug Administration Schedule; Drug Resistance; Etidronic Acid; Female; Follow-Up Studies; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans | 1989 |
[Paget's disease: errors to be avoided].
Topics: Adult; Alkaline Phosphatase; Calcitonin; Diagnostic Errors; Etidronic Acid; Humans; Hydroxyproline; Medication Errors; Osteitis Deformans | 1989 |
Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man.
Topics: Alkaline Phosphatase; Biopsy; Bone and Bones; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Organophosphonates; Paget Disease, Extramammary; Time Factors | 1987 |
Neoplastic hypercalcemia: physiologic response to intravenous etidronate disodium.
Topics: Adult; Aged; Aged, 80 and over; Calcifediol; Calcitriol; Calcium; Creatinine; Cyclic AMP; Etidronic Acid; Female; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Male; Paraneoplastic Endocrine Syndromes; Parathyroid Hormone; Phosphorus | 1987 |
Effective short term treatment of Paget's disease with oral etidronate.
Topics: Administration, Oral; Alkaline Phosphatase; Bone and Bones; Etidronic Acid; Humans; Hydroxyproline; Osteitis Deformans; Time Factors | 1986 |
Effects of intravenous etidronate disodium on skeletal and calcium metabolism.
Topics: Aged; Bone and Bones; Bone Diseases, Metabolic; Calcium; Etidronic Acid; Female; Humans; Hydroxyproline; Hypercalcemia; Male; Middle Aged; Neoplasms; Osteitis Deformans | 1987 |
Skeletal distribution and biochemical parameters of Paget's disease.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Antibodies; Bone and Bones; Etidronic Acid; Female; Humans; Hydroxyproline; Hypocalcemia; Male; Middle Aged; Organotechnetium Compounds; Osteitis Deformans; Parathyroid Hormone; Radiography; Radionuclide Imaging; Technetium | 1987 |
Procollagen-III peptide serum levels in Paget's disease of the bone.
Topics: Alkaline Phosphatase; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Humans; Hydroxyproline; Osteitis Deformans; Peptide Fragments; Procollagen | 1987 |
Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease.
Topics: Alkaline Phosphatase; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Humans; Hydroxyproline; Osteitis Deformans | 1987 |
[Effects of etidronate disodium (EHDP) on urogenital malignancies with bone metastasis: a multicentered collaborative evaluation].
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Calcium; Drug Evaluation; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteolysis; Pain, Intractable; Prostatic Neoplasms; Radionuclide Imaging; Urogenital Neoplasms | 1988 |
[EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
Topics: Aged; Alkaline Phosphatase; Calcium; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Radiography | 1985 |
[Treatment of Paget's disease with low dose sodium etidronate (5mg/kg/day). Occurrence of reversible transient suspected leukopenia].
Topics: Aged; Alkaline Phosphatase; Etidronic Acid; Female; Humans; Hydroxyproline; Leukocyte Count; Leukopenia; Male; Middle Aged; Osteitis Deformans; Phosphorus | 1985 |
[Usefulness of ethane-hydroxy-diphosphonate in the treatment of Paget's disease].
Topics: Aged; Alkaline Phosphatase; Drug Evaluation; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pain; Radiography; Radionuclide Imaging | 1985 |
Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
Topics: Adult; Aged; Alkaline Phosphatase; Biopsy; Bone Resorption; Calcitonin; Calcium; Clinical Enzyme Tests; Etidronic Acid; Humans; Hydroxyproline; Ilium; Male; Middle Aged; Organophosphorus Compounds; Osteitis Deformans; Recurrence | 1973 |
Therapeutic success in Paget disease.
Topics: Administration, Oral; Alkaline Phosphatase; Antineoplastic Agents; Calcitonin; Etidronic Acid; Humans; Hydroxyproline; Injections, Intramuscular; Injections, Subcutaneous; Organophosphorus Compounds; Osteitis Deformans; Osteoclasts | 1973 |
[Sodium etidronate (EHDP) and osteoporosis].
Topics: Adult; Aged; Bone Resorption; Calcium; Cyclic AMP; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteoporosis; Parathyroid Hormone; Phosphorus; Reflex Sympathetic Dystrophy | 1981 |
[Paget disease of the skeleton. Internal medicine aspects].
Topics: Alkaline Phosphatase; Calcitonin; Calcium; Diagnosis, Differential; Etidronic Acid; Humans; Hydroxyproline; Osteitis Deformans; Plicamycin; Prognosis | 1984 |
Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).
Topics: Adult; Aged; Alkaline Phosphatase; Blood Chemical Analysis; Cell Count; Drug Evaluation; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Osteoclasts; Pain; Radionuclide Imaging | 1983 |
Treatment of Paget's bone disease with the bisphosphonate APD.
Topics: Aged; Alkaline Phosphatase; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate | 1983 |
Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Drug Interactions; Etidronic Acid; Humans; Hydroxyproline; Middle Aged; Organotechnetium Compounds; Osteitis Deformans; Radionuclide Imaging; Technetium | 1984 |
Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
Topics: Aged; Alkaline Phosphatase; Calcitonin; Calcium; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate; Time Factors | 1984 |
APD in Paget's disease of bone. Role of the mononuclear phagocyte system?
Topics: Animals; Arthritis, Rheumatoid; Calcitonin; Clodronic Acid; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Humans; Hydroxyproline; Lymphocyte Activation; Osteitis Deformans; Pamidronate; Phagocytes; Rats; Zinc | 1980 |
Effects of two diphosphonates (EHDP and Cl2MDP) on serum uric acid in pagetic patients.
Topics: Adult; Aged; Alkaline Phosphatase; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Uric Acid | 1981 |
Use of etidronate (EHDP) in Paget's disease of bone.
Topics: Actuarial Analysis; Alkaline Phosphatase; Dose-Response Relationship, Drug; Etidronic Acid; Female; Fractures, Bone; Humans; Hydroxyproline; Osteitis Deformans | 1980 |
Long-term therapy of Paget's disease of bone with EHDP.
Topics: Aged; Alkaline Phosphatase; Bone and Bones; Etidronic Acid; Female; Humans; Hydroxyproline; Long-Term Care; Male; Middle Aged; Osteitis Deformans; Pain; Radiography; Radius Fractures | 1980 |
[Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Etidronic Acid; Female; Follow-Up Studies; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Parathyroid Hormone; Phosphorus | 1980 |
An apparent 1,25-dihydroxyvitamin D-independent stimulation of intestinal calcium absorption in patients with Paget disease of bone during a short-term diphosphonate therapy.
Topics: Aged; Alkaline Phosphatase; Calcitriol; Calcium; Dihydroxycholecalciferols; Etidronic Acid; Female; Humans; Hydroxyproline; Intestinal Absorption; Male; Middle Aged; Osteitis Deformans; Phosphorus | 1981 |
[Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
Topics: Aged; Alkaline Phosphatase; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans | 1981 |
[Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Minerals; Osteitis Deformans | 1982 |
[Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
Topics: Aged; Alkaline Phosphatase; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans | 1982 |
Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Resorption; Chromatography, High Pressure Liquid; Collagen; Drug Resistance; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Peptide Fragments; Tartrates; Testosterone | 1995 |
Hereditary hyperphosphatasia: 20 year follow-up and response to disodium etidronate.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Etidronic Acid; Family; Female; Follow-Up Studies; Humans; Hydroxyproline; Ilium; Male; Osteitis Deformans; Osteocalcin; Radiography; Radius; Ulna | 1994 |
Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Analysis of Variance; Bone Resorption; Calcium; Etidronic Acid; Female; Homeostasis; Humans; Hydroxyproline; Hyperparathyroidism; Kidney Tubules; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Postmenopause; Risedronic Acid | 1993 |
Therapeutic strategy in Paget's disease of bone.
Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Analgesics, Non-Narcotic; Biomarkers; Bone and Bones; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Hydroxyproline; Injections, Intravenous; Longitudinal Studies; Male; Middle Aged; Osteitis Deformans; Pamidronate; Radiography; Risk Assessment; Skull | 1995 |
Bone composition and metabolism after hyperbaric oxygenation in rats with 1-hydroxyethylidene-1,1-bisphosphonate-induced rickets.
Topics: Animals; Body Weight; Bone and Bones; Calcification, Physiologic; Calcium; Etidronic Acid; Hydroxyproline; Hyperbaric Oxygenation; Male; Phosphates; Random Allocation; Rats; Rats, Wistar; Rickets | 1996 |
Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol. The Liver Transplant Group, Groningen.
Topics: Absorptiometry, Photon; Adult; Biomarkers; Bone Density; Bone Resorption; Calcium; Creatinine; Etidronic Acid; Female; Humans; Hydroxycholecalciferols; Hydroxyproline; Liver Diseases; Liver Transplantation; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Radioimmunoassay; Retrospective Studies; Spinal Fractures | 1996 |
New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis.
Topics: Adult; Aged; Amino Acids; Biomarkers; Bone Diseases, Metabolic; Bone Resorption; Calcium; Collagen; Etidronic Acid; Female; Humans; Hydroxycholecalciferols; Hydroxyproline; Middle Aged; Osteoporosis, Postmenopausal; Peptide Fragments; Reference Values | 1996 |
Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcitriol; Calcium; Calcium Channel Blockers; Creatinine; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Parathyroid Hormone; Phosphorus; Risedronic Acid | 1998 |
A patient with Paget's disease of bone treated with etidronate disodium.
Topics: Aged; Alkaline Phosphatase; Etidronic Acid; Female; Humans; Hydroxyproline; Osteitis Deformans | 1998 |
A cysteine protease inhibitor prevents suspension-induced declines in bone weight and strength in rats.
Topics: Animals; Bone and Bones; Bone Resorption; Calcium; Cathepsin K; Cathepsins; Collagenases; Cysteine Proteinase Inhibitors; Etidronic Acid; Femur; Hydroxyproline; Leucine; Male; Organ Size; Rats; Rats, Wistar; Weightlessness | 2002 |
Therapeutic efficiency of dimephosphone and xydiphone in experimental pulse therapy with prednisolone.
Topics: Administration, Oral; Animals; Calcium; Catalase; Ceruloplasmin; Etidronic Acid; Female; Glucocorticoids; Hydroxyproline; Lipid Peroxidation; Male; Malondialdehyde; Organophosphorus Compounds; Phosphates; Phosphorus; Prednisolone; Rats; Therapies, Investigational; Time Factors | 2003 |